Investasi
Fitur
BiayaKeamanan
Akademi
Lainnya
Pluang+

Bandingkan Harga & Kinerja Pelayaran Nelly Dwi Putri Tbk. (NELY) vs Organon Pharma Indonesia Tbk. (SCPI)

Pelayaran Nelly Dwi Putri Tbk.Trading
Organon Pharma Indonesia Tbk.Trading

Kinerja harga (24 Jam Terakhir)

Statistik utama

Perbedaan Pelayaran Nelly Dwi Putri Tbk. dan Organon Pharma Indonesia Tbk.: Pelayaran Nelly Dwi Putri Tbk. diperdagangkan di Rp212 (kapitalisasi pasar 488,8 M, volume 24 jam 1,67 jt), sedangkan Organon Pharma Indonesia Tbk. diperdagangkan di Rp29.000 (kapitalisasi pasar 104,4 M). Perbedaan utamanya: Pelayaran Nelly Dwi Putri Tbk. jauh lebih besar — sekitar 4,7× kapitalisasi pasar Organon Pharma Indonesia Tbk.. Mana yang lebih baik tergantung tujuan investasimu.

NELYSCPI
Kapitalisasi Pasar
488,8 M104,4 M
Volume
1,67 jt
Lot
16,7 rb
Perputaran
347,77 jt
Harga Rata-rata
208,26
Nilai Transaksi
347,77 jt
Harga Ekuilibrium Indikatif
212
Volume Ekuilibrium Indikatif
161

Perbandingan imbal hasil

Imbal hasil berjalan pada periode standar

Berita terkini

Berita terbaru kedua aset

NELY
Lihat detail
SCPI
Lihat detail

Tentang Pelayaran Nelly Dwi Putri Tbk.

Pelayaran Nelly Dwi Putri, PT was established on 5 Feb 1977. The Company was founded with the name of PT Dwi Putri Nelly Chemical. Initially the business of the Company is engaged in general trade and industry, the chemical industry by producing glue for plywood used in the processing industry (plywood). Then in 1978 the Company began to expand its business in the wood processing industry (sawmills and plywood) and hauling logs for meet the needs of PT Panca Enterprises Palopo Palopo Plywood located in South Sulawesi. Company's focus in 1984 to run the field and ocean freight shipping services

Selengkapnya di halaman NELY

Tentang Organon Pharma Indonesia Tbk.

PT Merck Sharp Dohme Pharma Tbk was established within the frame work of the Foreign Capital Investment Law No. 1 year 1967 as amended by Law No. 11 year 1970 based on Notarial Deed No. 17 dated 7 March 1972 of Djojo Muljadi, S.H. The company originally incorporated as PT. Essex Indonesia, as a joint venture between Schering Corporation, a worldwide, research-based pharmaceutical enterprise headquartered in the United States, and an Indonesian businessman.

Selengkapnya di halaman SCPI